Filtered By:
Management: Funding
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 11357 results found since Jan 2013.
Setting high-impact clinical research priorities for the Society for Vascular Surgery
With the overall goal of enhancing the effectiveness and efficiency of vascular care, the Society for Vascular Surgery (SVS) recently completed a process by which it identified its top clinical research priorities to address critical gaps in knowledge guiding practitioners in prevention and treatment of vascular disease. After a survey of the SVS membership, a panel of SVS committee members and opinion leaders considered 53 distinct research questions through a structured process that resulted in identification of nine clinical issues that were felt to merit immediate attention by vascular investigators and external fundin...
Source: Journal of Vascular Surgery - January 21, 2013 Category: Surgery Authors: Larry W. Kraiss, Michael S. Conte, Randolph L. Geary, Melina Kibbe, C. Keith Ozaki Tags: Society for Vascular Surgery® documents Source Type: research
Vascular Cures Wylie Scholar Program
Vascular Cures' Wylie Scholar Program provides financial assistance to outstanding surgeons at the early stage of their careers, to help them develop as academic vascular surgeon-scientists. Vascular Cures has advanced breakthrough research since 1982. We've established a group of 16 surgeon-scientists at 13 institutions around the country who are transforming patient care. Vascular Cures' initial research investment of $8 million has enabled another $42 million in funding —producing $50 million for research. The Wylie Scholar Program has created a network of talented academic surgeons, many of who...
Source: ScanGrants feed - December 12, 2013 Category: Research Authors: Vascular Cures Source Type: funding
The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions.
Abstract
The SEARCH for Diabetes in Youth (SEARCH) study was initiated in 2000, with funding from the Centers for Disease Control and Prevention and support from the National Institute of Diabetes and Digestive and Kidney Diseases, to address major knowledge gaps in the understanding of childhood diabetes. SEARCH is being conducted at five sites across the U.S. and represents the largest, most diverse study of diabetes among U.S. youth. An active registry of youth diagnosed with diabetes at age <20 years allows the assessment of prevalence (in 2001 and 2009), annual incidence (since 2002), and trends by age, ra...
Source: Diabetes Care - November 25, 2014 Category: Endocrinology Authors: Hamman RF, Bell RA, Dabelea D, D'Agostino RB, Dolan L, Imperatore G, Lawrence JM, Linder B, Marcovina SM, Mayer-Davis EJ, Pihoker C, Rodriguez BL, Saydah S, for the SEARCH for Diabetes in Youth Study Group Tags: Diabetes Care Source Type: research
Avenu Medical wins CE Mark for Ellipsys vascular access system
Vascular access system maker Avenu Medical said today it won CE Mark approval in the European Union for its Ellipsys vascular access image-guided catheter system designed to percutaneously create arteriovenous fistulas for hemodialysis access.
The company also said it won investigational device exemption approval from the FDA for the device, claiming it is the 1st device to receive IDE clearance for the minimally invasive creation of arteriovenous fistulas.
“This is a major milestone both for our company and for the patients and physicians within the end stage renal disease communities. In the United States and arou...
Source: Mass Device - June 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Regulatory/Compliance Vascular Avenu Medical Source Type: news
Society for Vascular Surgery Multicenter Clinical Studies Planning Grant
Application Deadline: Letter of Intent: October 1, 2013 Full application, if invited: February 1, 2014 The SVS Foundation announces a funding opportunity directed to Society for Vascular Surgery (SVS) members developing grant applications for high-impact multicenter clinical studies in the treatment and/or prevention of vascular diseases. The SVS Foundation Multicenter Clinical Studies Planning Grant is one component of a broad strategy to facilitate clinical research directed at solving high-impact questions in the care of patients with vascular diseases. SVS recognizes that members face significant...
Source: ScanGrants feed - July 16, 2013 Category: Research Authors: Society for Vascular Surgery Source Type: funding
Society for Vascular Surgery Clinical Research Seed Grants
Application Deadline: January 17, 2014 In recognition of the importance of clinical investigation in vascular disease, the SVS Foundation announces the Clinical Research Seed Grant program. Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals: Encourage the interest and development of clinical investigators among the SVS membership, particularly junior members or those with limited prior experience as Principal Investigators ...
Source: ScanGrants feed - November 5, 2013 Category: Research Authors: Society for Vascular Surgery Source Type: funding
Society for Vascular Surgery Clinical Research Seed Grant Program
Application Deadline: December 15, 2014 In recognition of the importance of clinical investigation in vascular disease, the SVS Foundation announces the Clinical Research Seed Grant program. Purpose: It is vitally important, both to patients and to the specialty, that vascular surgeons play prominent roles in both industry and investigator-initiated clinical trials. The Clinical Research Seed Grant program has the following goals: • Encourage the interest and development of clinical investigators among the SVS membership, particularly junior members or those with limited prior experience as Principal Investig...
Source: ScanGrants feed - October 22, 2014 Category: Research Authors: Society for Vascular Surgery Source Type: funding
Vascular Flow Technologies raises $14.3m
Vascular Flow Technologies said today it raised $14.3 million (£10 million) through multiple rounds of financing to support research & development, strategic joint development and out-licensing agreements with industry partners.
The funding round consisted of 2 tranches; a $10 million (£7 million) loan note restructuring into Series A ordinary preference shares and a $4.3 million (£3 million) Series B financing round led by an undisclosed family office and joined by international and individual angel investors, the company said.
The U.K.-based company will use the funds as it shifts its focus towards operating as a...
Source: Mass Device - January 28, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Vascular Vascular Flow Technologies Source Type: news
QT Vascular raises $14m
QT Vascular said this week it inked a private placement deal with Gem Global Yield Fund for up to $14.3 million (SGD $20 million) over the next 30 months.
In the funding agreement, Singapore-based QT Vascular will receive up to $7.2 million (SGD $10 million) over the next 30 months, with an option for an additional $7.2 million on identical terms to the original agreement. The option is available for a period of 6 months, the company said.
Funds are slated to support repaying existing debt, improve cash flow and increase production to support its non-drug coated Chocolate PTA products.
“This agreement with GEM Globa...
Source: Mass Device - March 22, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters QT Vascular Source Type: news
Access Vascular raises $4m to support HydroPICC catheter
Medical device developer Access Vascular said today it raised $3.7 million to support its HydroPICC catheter designed to reduce thrombotic risk.
The HydroPICC is a peripherally inserted central catheter which the Bedford, Mass.-based company claims can significantly reduce the accumulation of platelets and the risk of thrombosis.
Financing will support the submission of an FDA 510(k) application for the company’s HydroPICC device later this year, the company said.
“We appreciate the support and engagement of all our investors. This latest round of funding comes at a critical and exciting time for Access Vascul...
Source: Mass Device - August 28, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Catheters Vascular accessvascular Source Type: news
Intact Vascular raises $20m in Series C
Intact Vascular said today it raised $20 million in a Series C round of financing, with funds slated to support the company’s Tack endovascular system through the FDA pre-market approval process.
The round was joined by major participants New Enterprise Associates, H.I.G. BioVentures and Quaker Partners, the Wayne, Penn.-based company said. The funding is slated to come in two stages or tranches, with the second closing later this year.
Late last week, the company posted an SEC filing showing that it had raised $10 million in a round of mixed financing, and that it was seeking an additional $11.8 million before closi...
Source: Mass Device - April 16, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Vascular Wall Street Beat Intact Vascular Source Type: news
Sara—the Search and Rescue Dog—and her Game of Fetch
Editor’s note: Jana Sweeny is the American Red Cross’s Director of International Communications. She and her team are traveling around Colombia this week, visiting communities made safer by the Red Cross.
As we walk into the Colombian Red Cross training center in Pereira, a yellow lab comes bouncing up, waving her tail enthusiastically. The ball in her mouth turns out to be a lime and she is ready to play fetch. Because I can never say no to a dog, I begin a game of “fetch the lime” with her.
It turns out that Sara isn’t just a fun companion–she is a retired search and rescue dog. The Colo...
Source: Red Cross Chat - January 24, 2014 Category: Global & Universal Authors: Jenelle Eli Tags: International Preparedness colombia dogs pets Search and Rescue South America Source Type: news
Pavmed eyes Q4 FDA submission for PortIO vascular access device
Pavmed (NSDQ:PAVMU) said today that it’s planning to submit an application for FDA clearance for its 1st product, the PortIO long-term implantable vascular access device, during the 4th quarter.
New York City-based Pavmed said the PortIO device is in the verification and validation testing phase, the final stage of pre-submission testing. The company has 4 other devices in development: The Caldus line disposable tissue ablation devices, including renal denervation for hypertension; the CarpX percutaneous device to treat carpal tunnel syndrome; the NextCath self-anchoring short-term catheter; and the NextFlo disposab...
Source: Mass Device - July 14, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Vascular Pavmed Source Type: news
Merit Medical backs Bluegrass Vascular ’ s Surfacer ‘ inside-out ’ catheter
Bluegrass Vascular Technologies said today that it entered a “strategic relationship” with Merit Medical (NSDQ:MMSI) for its Surfacer “inside-out” catheter that includes an equity stake and a distribution agreement.
The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union last August. The catheter is threaded through the femoral vein up to and into blockage in the jugular, which acts as a stabilizer. The head of the catheter is then aligned via fluoroscop...
Source: Mass Device - March 6, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Distribution Funding Roundup Vascular Wall Street Beat Bluegrass Vascular Technologies Merit Medical Systems Inc. Source Type: news
Vascular Dynamics raises $10m for MobiusHD
Vascular Dynamics said this week that it closed a private placement worth $10.4 million that it plans to use on the clinical program for its MobiusHD device for treating drug-resistant hypertension.
The MobiusHD implant is designed to reshape the carotid sinus to amplify the signals for baroreceptors lining the blood vessel. Implanted percutaneously, it’s designed to stimulate vasodilation.
All of Vascular Dynamics’ major backers participated the round of promissory notes convertible to Series C stock, the company said.
“We continue to be gratified in the confidence our current investor group shows in ...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiovascular Funding Roundup Hypertension Vascular Dynamics Source Type: news
